These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 29985971)
1. Computational analysis of kinase inhibitor selectivity using structural knowledge. Lo YC; Liu T; Morrissey KM; Kakiuchi-Kiyota S; Johnson AR; Broccatelli F; Zhong Y; Joshi A; Altman RB Bioinformatics; 2019 Jan; 35(2):235-242. PubMed ID: 29985971 [TBL] [Abstract][Full Text] [Related]
2. Structure-guided selection of specificity determining positions in the human Kinome. Moll M; Finn PW; Kavraki LE BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):431. PubMed ID: 27556159 [TBL] [Abstract][Full Text] [Related]
3. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis. Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Anastassiadis T; Deacon SW; Devarajan K; Ma H; Peterson JR Nat Biotechnol; 2011 Oct; 29(11):1039-45. PubMed ID: 22037377 [TBL] [Abstract][Full Text] [Related]
6. Perspective on computational and structural aspects of kinase discovery from IPK2014. Martin E; Knapp S; Engh RA; Moebitz H; Varin T; Roux B; Meiler J; Berdini V; Baumann A; Vieth M Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1595-604. PubMed ID: 25861861 [TBL] [Abstract][Full Text] [Related]
7. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome. Martin E; Mukherjee P J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092 [TBL] [Abstract][Full Text] [Related]
8. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity. Verkhivker GM Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284 [TBL] [Abstract][Full Text] [Related]
9. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway. Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663 [TBL] [Abstract][Full Text] [Related]
10. Strategy toward Kinase-Selective Drug Discovery. Zhang M; Liu Y; Jang H; Nussinov R J Chem Theory Comput; 2023 Mar; 19(5):1615-1628. PubMed ID: 36815703 [TBL] [Abstract][Full Text] [Related]
11. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery. Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645 [TBL] [Abstract][Full Text] [Related]
12. Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket. Forster M; Chaikuad A; Bauer SM; Holstein J; Robers MB; Corona CR; Gehringer M; Pfaffenrot E; Ghoreschi K; Knapp S; Laufer SA Cell Chem Biol; 2016 Nov; 23(11):1335-1340. PubMed ID: 27840070 [TBL] [Abstract][Full Text] [Related]
13. What Makes a Kinase Promiscuous for Inhibitors? Hanson SM; Georghiou G; Thakur MK; Miller WT; Rest JS; Chodera JD; Seeliger MA Cell Chem Biol; 2019 Mar; 26(3):390-399.e5. PubMed ID: 30612951 [TBL] [Abstract][Full Text] [Related]
14. Development of Kinase-Centric Drugs: A Computational Perspective. Pratap Reddy Gajulapalli V ChemMedChem; 2023 Oct; 18(19):e202200693. PubMed ID: 37442809 [TBL] [Abstract][Full Text] [Related]
15. Multimodal multi-task deep neural network framework for kinase-target prediction. Hua Y; Luo L; Qiu H; Huang D; Zhao Y; Liu H; Lu T; Chen Y; Zhang Y; Jiang Y Mol Divers; 2023 Dec; 27(6):2491-2503. PubMed ID: 36369613 [TBL] [Abstract][Full Text] [Related]
17. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation. Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204 [TBL] [Abstract][Full Text] [Related]
18. DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors. Ung PM; Schlessinger A ACS Chem Biol; 2015 Jan; 10(1):269-78. PubMed ID: 25420233 [TBL] [Abstract][Full Text] [Related]
19. Structural insights into AGC kinase inhibition. Breitenlechner C; Gassel M; Engh R; Bossemeyer D Oncol Res; 2004; 14(6):267-78. PubMed ID: 15206489 [TBL] [Abstract][Full Text] [Related]